Provexis plc (PXS.L) LSE

Currency In GBp

AD

Provexis plc

Address

2 Blagrave Street

Reading, RG1 1AZ

United Kingdom of Great Britain and Northern Ireland (the)

Phone

44 7490 391 888

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

2

First IPO Date

June 28, 2004

Key Executives

NameTitlePayYear Born
Ian FordChief Executive Officer, Chief Financial Officer, Company Secretary & Executive Director185,6091965
Niamh Ann O'KennedyChief Scientific Officer, Member of Scientific Advisory Board & Executive Director39,7321973
Asim K. Duttaroy FICNConsultant & Member of Scientific Advisory Board0N/A
AD

Description

Operating globally, Provexis plc, along with its associated companies, specializes in the creation, licensing, and commercialization of functional foods, medical nutritional products, and dietary supplements. A key offering is Fruitflow, a unique tomato extract designed to reduce the tendency for abnormal blood clot formation, which is linked to severe cardiovascular conditions such as heart attacks and strokes. This versatile extract is available in syrup and powder formats for integration into various food and beverage items, as well as dietary supplements. The company also provides Fruitflow + Omega-3, a capsule-based supplement aimed at fostering healthy blood circulation and supporting normal cardiac function. Provexis plc holds a strategic collaboration agreement with By-Health Co., Ltd. Its products are distributed through both physical retail channels and digital online platforms. Founded in 1999, Provexis plc has its headquarters situated in Reading, United Kingdom.

AD